Page last updated: 2024-11-11

ms 8209

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

MS 8209: an amphotericin B derivative with antifungal and antiviral properties; inhibits HIV-1 replication; prevents membrane expression of HIV-1 large envelope glycoprotein gp120; tested against scrapie [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6436189
MeSH IDM0201506

Synonyms (6)

Synonym
ms-8209 ,
ms 8209
ms8209
1-deoxy-1-amino-4,6-o-benzylidene-d-fructosyl amphotericin b, n-methyl glucamine salt
136458-97-4
1-deoxy-1-amino-4,6-o-benzylidene-fructosyl-amphotericin b

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
", the dosage inducing less than 15% mortality due to toxicity; the efficacies of MS-8209 and D-AmB at their respective maximum tolerated dosages were compared."( Activity of MS-8209, a nonester amphotericin B derivative, in treatment of experimental systemic mycoses.
Carbon, C; Joly, V; Saint-Julien, L; Seman, M; Yeni, P, 1992
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's10 (58.82)18.2507
2000's7 (41.18)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.79 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.19 (4.65)
Search Engine Demand Index38.04 (26.88)
Search Engine Supply Index2.95 (0.95)

This Compound (25.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (95.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]